Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 553Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Adcirca

02 10Cialis

PharmaCompass

01

Brand Name : Adcirca

Tadalafil

arrow
Pharmex
Not Confirmed

Brand Name : Adcirca

arrow
Pharmex
Not Confirmed

Tadalafil

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2019 Revenue in Millions : 107

2018 Revenue in Millions : 324

Growth (%) : -67

blank

02

Brand Name : Cialis

Tadalafil

arrow
Pharmex
Not Confirmed

03

Brand Name : Adcirca

Tadalafil

arrow
Pharmex
Not Confirmed

Brand Name : Adcirca

arrow
Pharmex
Not Confirmed

Tadalafil

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 67

2019 Revenue in Millions : 107

Growth (%) : -37

blank

04

Brand Name : Cialis

Tadalafil

arrow
Pharmex
Not Confirmed

05

Brand Name : Adcirca

Tadalafil

arrow
Pharmex
Not Confirmed

Brand Name : Adcirca

arrow
Pharmex
Not Confirmed

Tadalafil

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2021 Revenue in Millions : 56

2020 Revenue in Millions : 67

Growth (%) : -17

blank

06

Brand Name : Cialis

Tadalafil

arrow
Pharmex
Not Confirmed

07

Brand Name : Cialis

Tadalafil

arrow
Pharmex
Not Confirmed

08

Brand Name : Adcirca

Tadalafil

arrow
Pharmex
Not Confirmed

Brand Name : Adcirca

arrow
Pharmex
Not Confirmed

Tadalafil

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 41

2021 Revenue in Millions : 56

Growth (%) : -26

blank

09

Brand Name : Adcirca

Tadalafil

arrow
Pharmex
Not Confirmed

Brand Name : Adcirca

arrow
Pharmex
Not Confirmed

Tadalafil

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 29

2022 Revenue in Millions : 41

Growth (%) : -30

blank

10

Brand Name : Adcirca

Tadalafil

arrow
Pharmex
Not Confirmed

Brand Name : Adcirca

arrow
Pharmex
Not Confirmed

Tadalafil

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2024 Revenue in Millions : 24

2023 Revenue in Millions : 29

Growth (%) : -18

blank